Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 2 | 2019 | 150 | 1.150 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 30 | 0.690 |
Why?
|
| Hyperthyroidism | 1 | 2019 | 13 | 0.670 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 286 | 0.670 |
Why?
|
| Magnesium Sulfate | 1 | 2018 | 6 | 0.640 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 50 | 0.600 |
Why?
|
| Prenatal Care | 1 | 2018 | 117 | 0.600 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 85 | 0.580 |
Why?
|
| Mandatory Programs | 1 | 2016 | 8 | 0.540 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 317 | 0.520 |
Why?
|
| Papillomavirus Vaccines | 1 | 2016 | 93 | 0.490 |
Why?
|
| Vaccination | 1 | 2016 | 189 | 0.480 |
Why?
|
| Pregnancy | 6 | 2023 | 2334 | 0.420 |
Why?
|
| Infant, Newborn | 3 | 2023 | 2455 | 0.250 |
Why?
|
| Stillbirth | 1 | 2023 | 12 | 0.220 |
Why?
|
| Antithyroid Agents | 2 | 2019 | 20 | 0.210 |
Why?
|
| Preconception Care | 2 | 2019 | 14 | 0.210 |
Why?
|
| Thyroid Function Tests | 2 | 2019 | 21 | 0.210 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 81 | 0.200 |
Why?
|
| Misoprostol | 1 | 2020 | 6 | 0.180 |
Why?
|
| Povidone | 1 | 2020 | 12 | 0.180 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2020 | 8 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2023 | 7277 | 0.180 |
Why?
|
| Cellulose | 1 | 2020 | 22 | 0.180 |
Why?
|
| Sewage | 1 | 2019 | 23 | 0.170 |
Why?
|
| Placenta | 1 | 2020 | 101 | 0.170 |
Why?
|
| Postpartum Thyroiditis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2019 | 4 | 0.170 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2019 | 34 | 0.170 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 57 | 0.170 |
Why?
|
| Female | 7 | 2023 | 38074 | 0.170 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 33 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2019 | 434 | 0.140 |
Why?
|
| Virginia | 1 | 2016 | 45 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2016 | 99 | 0.130 |
Why?
|
| Logistic Models | 1 | 2018 | 1420 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1745 | 0.120 |
Why?
|
| Humans | 7 | 2023 | 68618 | 0.120 |
Why?
|
| Parents | 1 | 2016 | 312 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 1026 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 767 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2016 | 2358 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2800 | 0.080 |
Why?
|
| Time Factors | 1 | 2016 | 4655 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7029 | 0.070 |
Why?
|
| Child | 1 | 2016 | 6405 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2023 | 56 | 0.050 |
Why?
|
| Fetal Development | 1 | 2023 | 70 | 0.050 |
Why?
|
| Birth Weight | 1 | 2023 | 186 | 0.050 |
Why?
|
| Gestational Age | 1 | 2023 | 389 | 0.050 |
Why?
|
| Excipients | 1 | 2020 | 8 | 0.050 |
Why?
|
| Administration, Intravaginal | 1 | 2020 | 11 | 0.050 |
Why?
|
| Forensic Pathology | 1 | 2020 | 19 | 0.050 |
Why?
|
| Organ Size | 1 | 2020 | 242 | 0.040 |
Why?
|
| Propylthiouracil | 1 | 2019 | 8 | 0.040 |
Why?
|
| Methimazole | 1 | 2019 | 9 | 0.040 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2019 | 20 | 0.040 |
Why?
|
| Male | 1 | 2018 | 37321 | 0.030 |
Why?
|
| Adult | 1 | 2019 | 21403 | 0.010 |
Why?
|